Evidence map›Paper›PMID 38157062›Full record

ArticleParasitology research2023

The use of recombinant K39, KMP11, and crude antigen-based indirect ELISA as a serological diagnostic tool and a measure of exposure for cutaneous leishmaniasis in Sri Lanka.

Charani Karunathilake, Narmadha Alles, Rajika Dewasurendra, Isurika Weerasinghe, Nipuni Chandrasiri, Sachee Bhanu Piyasiri, Nilakshi Samaranayake, Hermali Silva, Nuwani Manamperi, Nadira Karunaweera

Open access · greenAbstract read
In one paragraph

Article in Parasitology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Charani KarunathilakeFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Narmadha AllesFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Rajika DewasurendraFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Isurika WeerasingheFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Nipuni ChandrasiriFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Sachee Bhanu PiyasiriFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Nilakshi SamaranayakeFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Hermali SilvaFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka.
Nuwani ManamperiFaculty of Medicine, Department of Parasitology, University of Kelaniya, Ragama, Sri Lanka.
Nadira KarunaweeraFaculty of Medicine, Department of Parasitology, University of Colombo, Colombo, Sri Lanka. nadira@parasit.cmb.ac.lk.
University of Colombo · LKUniversity of Kelaniya · LK

Funding

Epidemiology and transmission of Leishmania donovani infections in Sri Lanka and BhutanU01AI136033 · NIAID · UNIVERSITY OF COLOMBO · PI KARUNAWEERA, NADIRA DHARSHANI, ZHOU, GUOFA · 2017 to 2021
$2.0M
National Institute of Allergy and Infectious Diseases of the National Institute of Health, USA U01AI136033NIAID NIH HHS U01 AI136033
6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) in Sri Lanka is caused by Leishmania donovani, a parasite widely known to cause visceral leishmaniasis. Despite the fact that CL is not generally believed to elicit serological immune responses, recent studies show the presence of antibody responses against this atypical form of CL. This study assesses the potential of using recombinant K39 (rK39), KMP11, and crude parasite antigen-based indirect ELISAs as serological diagnostic tools and measures of exposure for CL in Sri Lanka. The study used serum samples from confirmed CL patients (n = 266) and apparently healthy individuals from endemic settings (n = 411). Serum samples from individuals residing in non-endemic areas were used as negative controls. In-house indirect ELISAs were optimized and validated for recombinant antigens. Previously validated crude parasite extract-based indirect ELISA was performed for comparison. The statistical analyses were performed using SPSS v26.0. The rK39 (sensitivity = 71.2%, specificity = 64%) and KMP11 (sensitivity = 79.2%, specificity = 71.4%) based indirect ELISA were shown to be less suitable for the diagnosis of CL, while crude parasite extract-based indirect ELISA (sensitivity = 82.4%, specificity = 85.7%) might be a better method of diagnosis. All 03 ELISAs seemed to be good methods as measures of exposure since correlations were observed between the seropositivity of all 03 ELISAs (rK39: p = 0.037, KMP11: p = 0.007, CrudeAg: p = 0.000) with provincial case incidences. The findings will be important in identifying the disease hotspots in order to design the control measures for CL induced by L. donovani in Sri Lanka.

Indexed as

Leishmania donovaniLeishmaniasis, CutaneousLeishmaniasis, VisceralAntigens, ProtozoanEnzyme-Linked Immunosorbent AssayHumansSri LankaAntigens, ProtozoanAsymptomaticLaboratory diagnosisLeishmania donovaniSero-prevalence

Identifiers

PMID38157062
PMCPMC11263736
OpenAlexW4390392732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.